Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability, Current in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $4.17M, a 17.2% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.17M +$613K +17.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.64M +$108K +3.06% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.61M -$955K -20.9% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $3.58M -$3.66M -50.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.56M -$4.19M -54% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.53M -$4.11M -53.8% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.57M -$2.17M -32.2% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $7.25M +$1.16M +19.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $7.74M +$2.15M +38.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.64M +$2.06M +37% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.73M +$1.19M +21.5% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $6.08M +$815K +15.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $5.6M +$1.62M +40.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $5.57M +$2.36M +73.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $5.54M +$2.35M +73.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $5.27M +$2.98M +130% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.97M +$1.71M +75.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.21M +$338K +11.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.19M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.29M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $2.26M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $2.87M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.